Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kairui Feng

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2022
Quantitative methods and modeling to assess COVID-19-interrupted in vivo pharmacokinetic bioequivalence studies with two reference batchesYuqing Gong, Kairui Feng, Peijue Zhang, et al.
Eclinicalmedicine|September 29, 2021
Association of partial systemic exposure and abuse potential for opioid analgesics with abuse deterrence labeling claims supporting product-specific guidanceLiang Zhao, Zhichuan Li, Lanyan Fang, et al.
The AAPS Journal|October 30, 2020
New Model-Based Bioequivalence Statistical Approaches for Pharmacokinetic Studies with Sparse SamplingFlorence Loingeville, Julie Bertrand, Thu Thuy Nguyen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 16, 2022
Impact of model misspecification on model-based tests in PK studies with parallel design: real case and simulation studiesMélanie Guhl, François Mercier, Carsten Hofmann, et al.
The AAPS Journal|April 2, 2026
Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of particle Size on Formulation VariabilityNatalie M Morris, Alexandre Djehizian, Naresh Mittapelly, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 29, 2025
Shuxuening injection improves myocardial injury after myocardial infarction by regulating macrophage polarization via the TLR4/NF-κB and PI3K/Akt signaling pathwaysXiaoshuai Zhang, Liuqing Yang, Kairui Feng, et al.
Journal of Medicinal Chemistry|October 15, 2023
Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly ModulatorsMei Wang, Jian Zhang, Yutong Dou, et al.
Clinical Pharmacology and Therapeutics|February 8, 2022
Considerations for the Forced Expiratory Volume in 1 Second-Based Comparative Clinical Endpoint Bioequivalence Studies for Orally Inhaled Drug ProductsJieon Lee, Kairui Feng, Denise S Conti, et al.
Clinical and Translational Science|April 30, 2022
A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalenceScott A Mosley, Sarah Kim, Nihal El Rouby, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 17, 2020
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity ScoresCameron D Thomas, Scott A Mosley, Sarah Kim, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2022
Quantitative methods and modeling to assess COVID-19-interrupted in vivo pharmacokinetic bioequivalence studies with two reference batchesYuqing Gong, Kairui Feng, Peijue Zhang, et al.
Eclinicalmedicine|September 29, 2021
Association of partial systemic exposure and abuse potential for opioid analgesics with abuse deterrence labeling claims supporting product-specific guidanceLiang Zhao, Zhichuan Li, Lanyan Fang, et al.
The AAPS Journal|October 30, 2020
New Model-Based Bioequivalence Statistical Approaches for Pharmacokinetic Studies with Sparse SamplingFlorence Loingeville, Julie Bertrand, Thu Thuy Nguyen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|September 16, 2022
Impact of model misspecification on model-based tests in PK studies with parallel design: real case and simulation studiesMélanie Guhl, François Mercier, Carsten Hofmann, et al.
The AAPS Journal|April 2, 2026
Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of particle Size on Formulation VariabilityNatalie M Morris, Alexandre Djehizian, Naresh Mittapelly, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|January 29, 2025
Shuxuening injection improves myocardial injury after myocardial infarction by regulating macrophage polarization via the TLR4/NF-κB and PI3K/Akt signaling pathwaysXiaoshuai Zhang, Liuqing Yang, Kairui Feng, et al.
Journal of Medicinal Chemistry|October 15, 2023
Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly ModulatorsMei Wang, Jian Zhang, Yutong Dou, et al.
Clinical Pharmacology and Therapeutics|February 8, 2022
Considerations for the Forced Expiratory Volume in 1 Second-Based Comparative Clinical Endpoint Bioequivalence Studies for Orally Inhaled Drug ProductsJieon Lee, Kairui Feng, Denise S Conti, et al.
Clinical and Translational Science|April 30, 2022
A randomized, cross-over trial of metoprolol succinate formulations to evaluate PK and PD end points for therapeutic equivalenceScott A Mosley, Sarah Kim, Nihal El Rouby, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 17, 2020
Examination of Metoprolol Pharmacokinetics and Pharmacodynamics Across CYP2D6 Genotype-Derived Activity ScoresCameron D Thomas, Scott A Mosley, Sarah Kim, et al.
Pageof 5